We are live on ! Find out more
JC

Jacobs & Co Portfolio holdings

AUM $1.17B
1-Year Est. Return 37.3%
This Fund
S&P 500
This Quarter Est. Return
+0.76%
1 Year Est. Return
+37.3%
3 Year Est. Return
+92.23%
5 Year Est. Return
+114.23%
10 Year Est. Return
+410.55%
AUM
$983M
AUM Growth
-$17.1M
Cap. Flow
-$12M
Cap. Flow %
-1.22%
Top 10 Hldgs %
32.2%
Holding
127
New
1
Increased
30
Reduced
69
Closed
1

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$6.33M
2
AMT icon
American Tower
AMT
+$2.44M
3
AMD icon
Advanced Micro Devices
AMD
+$1.5M
4
TMO icon
Thermo Fisher Scientific
TMO
+$810K
5
PEP icon
PepsiCo
PEP
+$796K

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$3.96M
2
BDX icon
Becton Dickinson
BDX
+$2.95M
3
NVDA icon
NVIDIA
NVDA
+$2.23M
4
AAPL icon
Apple
AAPL
+$1.47M
5
META icon
Meta Platforms (Facebook)
META
+$1.42M

Sector Composition

Rank Sector Weight
1 Technology 30.47%
2 Industrials 14.96%
3 Healthcare 13.62%
4 Consumer Discretionary 11.76%
5 Consumer Staples 10.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCHW
26
Charles Schwab
SCHW
$183B
$12.4M 1.26%
167,637
-5,027
-3% -$376K
MCD icon
27
McDonald's
MCD
$192B
$12.4M 1.26%
42,776
-462
-1% -$138K
CMI icon
28
Cummins
CMI
$87.5B
$12.3M 1.25%
35,184
-1,505
-4% -$529K
NKE icon
29
Nike
NKE
$61.9B
$11.9M 1.21%
156,955
+6,137
+4% +$482K
ENB icon
30
Enbridge
ENB
$119B
$11.7M 1.2%
276,859
-2,726
-1% -$114K
AMGN icon
31
Amgen
AMGN
$208B
$11.5M 1.17%
44,156
+78
+0.2% +$23.1K
MKC icon
32
McCormick & Company Non-Voting
MKC
$13.7B
$11.4M 1.16%
149,685
+3,020
+2% +$237K
MRK icon
33
Merck
MRK
$322B
$11.3M 1.15%
113,641
+4,751
+4% +$490K
UPS icon
34
United Parcel Service
UPS
$88.6B
$11.2M 1.14%
88,746
+691
+0.8% +$90.9K
AMAT icon
35
Applied Materials
AMAT
$403B
$11.2M 1.14%
68,673
+2,690
+4% +$488K
SNPS icon
36
Synopsys
SNPS
$74.4B
$10.8M 1.1%
22,266
+1,424
+7% +$744K
ABBV icon
37
AbbVie
ABBV
$443B
$10.8M 1.1%
60,614
-312
-0.5% -$57.4K
AMD icon
38
Advanced Micro Devices
AMD
$776B
$10.8M 1.09%
89,030
+10,404
+13% +$1.5M
AXP icon
39
American Express
AXP
$227B
$10.7M 1.08%
35,899
-2,413
-6% -$693K
BA icon
40
Boeing
BA
$171B
$10.2M 1.04%
57,741
-2,051
-3% -$322K
SYY icon
41
Sysco
SYY
$40.8B
$9.95M 1.01%
130,097
-739
-0.6% -$56.6K
EW icon
42
Edwards Lifesciences
EW
$49.6B
$9.31M 0.95%
125,728
+2,828
+2% +$198K
NOW icon
43
ServiceNow
NOW
$115B
$9.21M 0.94%
43,430
-1,650
-4% -$334K
HUBB icon
44
Hubbell
HUBB
$25B
$9.16M 0.93%
21,867
-1,020
-4% -$455K
FISV
45
Fiserv Inc
FISV
$28.8B
$8.98M 0.91%
43,711
-2,553
-6% -$521K
ROK icon
46
Rockwell Automation
ROK
$53.4B
$8.71M 0.89%
30,496
+530
+2% +$149K
STZ icon
47
Constellation Brands
STZ
$22.2B
$8.66M 0.88%
39,189
+1,564
+4% +$372K
EA icon
48
Electronic Arts
EA
$53B
$8.55M 0.87%
58,436
-795
-1% -$122K
INTU icon
49
Intuit
INTU
$86.5B
$8.39M 0.85%
13,348
+359
+3% +$229K
JNJ icon
50
Johnson & Johnson
JNJ
$618B
$8.18M 0.83%
56,569
+179
+0.3% +$27.7K
1
2
3 4 5

Similar funds

OCAI
O'Connor Alternative Investments New York $1.17B AUM
BONST
Bank of Nova Scotia Trust Toronto, Ontario, Canada $1.16B AUM 27.04% 1-Year Est. Return
AMI
Amica Mutual Insurance Providence, Rhode Island $1.16B AUM 21.34% 1-Year Est. Return
GAB
German American Bancorp Jasper, Indiana $1.16B AUM 25.7% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
FG
Fiduciary Group Savannah, Georgia $1.17B AUM 16.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Jacobs & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Jacobs & Co held 127 positions worth $983M, down 1.7% from $1B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 1.6%. Jacobs & Co opened 1 new position and exited 1, leaving the 127-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 30% a quarter earlier, followed by Industrials and Healthcare.

  • Jacobs & Co's largest Q4 2024 buy was Blackrock: 198 shares worth $202K.
  • Jacobs & Co added most to Eli Lilly in Q4 2024, an estimated $6.33M increase.
  • Jacobs & Co's biggest Q4 2024 reduction was Becton Dickinson, cutting an estimated $2.95M.
  • Jacobs & Co fully exited GSK in Q4 2024, selling an estimated $3.96M.
  • Jacobs & Co's ten largest holdings make up 32% of its $983M portfolio in Q4 2024.
  • Jacobs & Co opened 1 new position and closed 1 in Q4 2024.
  • Jacobs & Co's portfolio value fell 1.7% quarter-over-quarter to $983M.

Based on Jacobs & Co's 13F filing for Q4 2024, filed 10 Jan 2025.